This is the second volume of the comprehensive, two-volume work on
oxidative stress in lung diseases. Adopting a multidisciplinary
approach, it demonstrates the cellular and molecular mechanisms
associated with ROS (reactive oxygen species)-induced initiation and
progression of a variety of lung diseases, such as COPD, emphysema,
asthma, cystic fibrosis, occupational pulmonary diseases and pulmonary
hypertension and discusses points for therapeutic intervention. The book
also covers translational research and the latest research on prevention
and therapeutics. Each chapter includes in-depth insights into the
mechanisms associated with lung diseases and into identifying targets
for drug development. Bridging the gap between fundamental and
translational research, and examining applications in the biomedical and
pharmaceutical industry, it is a thought- provoking read for basic and
applied scientists engaged in biomedical research.